Structure of the psychotic disorders classification in DSM-5

Schizophrenia Research

Volumn 150, Issue 1, 2013, Pages 11-14

  Heckers, Stephan ^a   Barch, Deanna M ^b   Bustillo, Juan ^c   Gaebel, Wolfgang ^d   Gur, Raquel ^e   Malaspina, Dolores ^f,g   Owen, Michael J ^h   Schultz, Susan ⁱ   Tandon, Rajiv ^j   Tsuang, Ming ^k   Van Os, Jim ^l   Carpenter, William ^m  

^a VANDERBILT UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

^d Department of Orthopedic Surgery   (Germany)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f NEW YORK UNIVERSITY   (United States)

^g Creedmoor Psychiatric Center   (United States)

^h CARDIFF UNIVERSITY   (United Kingdom)

ⁱ UNIVERSITY OF IOWA   (United States)

^j UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^m MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

more..

Author keywords

Diagnosis; DSM; Nosology; Psychotic disorders; Schizophrenia

Indexed keywords

CATATONIA; CLINICAL FEATURE; CRITERION VARIABLE; DELUSIONAL DISORDER; DISEASE CLASSIFICATION; DISEASE SEVERITY; DSM-5; HUMAN; MENTAL DISEASE; PATIENT ASSESSMENT; PERCEPTION; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER; STRUCTURE ANALYSIS; VALIDITY;

DIAGNOSIS; DSM; NOSOLOGY; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; PSYCHOTIC DISORDERS;

EID: 84884149532     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.04.039     Document Type: Review

References (33)

1. Allardyce J., Gaebel W., Zielasek J., van Os J. Deconstructing Psychosis Conference February 2006: the validity of schizophrenia and alternative approaches to the classification of psychosis. Schizophr. Bull. 2007, 33(4):863-867.
2. Andreasen N.C. Understanding schizophrenia: a silent spring?. Am. J. Psychiatry 1998, 155:1657-1659.
3. Barch D.M., Bustillo J., Gaebel W., Gur R.E., Heckers S., Malaspina D., Owen M.J., Schultz S., Tandon R., Tsuang M.T., Van Os J., Carpenter W. Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis. Schizophr. Res. 2013, 150(1):15-20. (this issue).
4. Blanchard J.J., Cohen A.S. The structure of negative symptoms within schizophrenia: implications for assessment. Schizophr. Bull. 2006, 32(2):238-245.
5. Bruno R.M. Synchrony in sensation. Curr. Opin. Neurobiol. 2011, 21(5):701-708.
6. Bustillo J., Heckers S., Tandon R., Barch D.M., Gaebel W., Gur R.E., Malaspina D., Owen M.J., Schultz S., Tsuang M.T., Van Os J., Carpenter W. Catatonia in DSM-5. Schizophr. Res. 2013, 150(1):26-30. (this issue).
7. Cermolacce M., Sass L., Parnas J. What is bizarre in bizarre delusions? A critical review. Schizophr. Bull. 2010, 36(4):667-679.
8. Coltheart M., Langdon R., McKay R. Delusional belief. Annu. Rev. Psychol. 2011, 62:271-298.
9. Cuthbert B.N., Insel T.R. Toward new approaches to psychotic disorders: the NIMH Research Domain Criteria project. Schizophr. Bull. 2010, 36(6):1061-1062.
10. Der-Avakian A., Markou A. The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci. 2012, 35(1):68-77.
11. Fink M., Taylor M.A. Issues for DSM-V: the medical diagnostic model. Am. J. Psychiatry 2008, 165(7):799.
12. Fischer B.A., Carpenter W.T. Will the Kraepelinian dichotomy survive DSM-V?. Neuropsychopharmacol. 2009, 34(9):2081-2087.
13. Foussias G., Remington G. Negative symptoms in schizophrenia: avolition and Occam's razor. Schizophr. Bull. 2010, 36:359-369.
14. Gigerenzer G., Gaissmaier W. Heuristic decision making. Annu. Rev. Psychol. 2011, 62:451-482.
15. Heckers S. Making progress in schizophrenia research. Schizophr. Bull. 2008, 34(4):591-594.
16. Heckers S. Bleuler and the neurobiology of schizophrenia. Schizophr. Bull. 2011, 37(6):1131-1135.
17. Heckers S., Tandon R., Bustillo J. Catatonia in the DSM-shall we move or not?. Schizophr. Bull. 2010, 36(2):205-207.
18. Hyman S.E. Can neuroscience be integrated into the DSM-V? Nature reviews. Neuroscience 2007, 8(9):725-732.
19. Insel T.R. Rethinking schizophrenia. Nature 2010, 468(7321):187-193.
20. Kring A.M., Gur R.E., Blanchard J.J., Horan W.P., Reise S.P. The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation. Am. J. Psychiatry 2013, 170(2):165-172.
21. Kupfer D.J., Regier D.A. Neuroscience, clinical evidence, and the future of psychiatric classification in DSM-5. Am. J. Psychiatry 2011, 168(7):672-674.
22. Lieberman J.A., First M.B. Renaming schizophrenia. Bmj 2007, 334(7585):108.
23. Malaspina D., Owen M.J., Heckers S., Tandon R., Bustillo J., Schultz S., Barch D.M., Gaebel W., Gur R.E., Tsuang M.T., Van Os J., Carpenter W. Schizoaffective disorder in the DSM-5. Schizophr. Res. 2013, 150(1):21-25. (this issue).
24. Messinger J.W., Tremeau F., Antonius D., Mendelsohn E., Prudent V., Stanford A.D., Malaspina D. Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research. Clin. Psychol. Rev. 2011, 31(1):161-168.
25. Peralta V., Campos M.S., de Jalon E.G., Cuesta M.J. DSM-IV catatonia signs and criteria in first-episode, drug-naive, psychotic patients: psychometric validity and response to antipsychotic medication. Schizophr. Res. 2010, 118(1-3):168-175.
26. Regier D.A., Narrow W.E., Clarke D.E., Kraemer H.C., Kuramoto S.J., Kuhl E.A., Kupfer D.J. DSM-5 field trials in the United States and Canada. Part II: test-retest reliability of selected categorical diagnoses. Am. J. Psychiatry 2013, 170:59-70.
27. Siever L.J., Davis K.L. The pathophysiology of schizophrenia disorders: perspectives from the spectrum. Am. J. Psychiatry 2004, 161:398-413.
28. Spitzer M. On defining delusions. Compr. Psychiatry 1990, 31(5):377-397.
29. Strauss G.P., Frank M.J., Waltz J.A., Kasanova Z., Herbener E.S., Gold J.M. Deficits in positive reinforcement learning and uncertainty-driven exploration are associated with distinct aspects of negative symptoms in schizophrenia. Biol. Psychiatry 2011, 69(5):424-431.
30. Tandon R., Carpenter W.T. DSM-5 status of psychotic disorders: 1year prepublication. Schizophr. Bull. 2012, 38(3):369-370.
31. Tandon R., Gaebel W., Barch D., Bustillo J., Gur R., Heckers S., Malaspina D., Owen M.J., Schultz S., Tsuang M.T., Van Os J., Carpenter W. Definition and description of schizophrenia in the DSM-5. Schizophr. Res. 2013, 150(1):3-10. (this issue).
32. Tsuang M.T., Van Os J., Tandon R., Barch D.M., Bustillo J., Gaebel W., Gur R.E., Heckers S., Malaspina D., Owen M.J., Schultz S., Carpenter W. Attentuated psychosis syndrome in DSM-5. Schizophr. Res. 2013, 150(1):31-35. (this issue).
33. Umehara H., Fangerau H., Gaebel W., Kim Y., Schott H., Zielasek J. From "schizophrenia" to "disturbance of the integrity of the self": causes and consequences of renaming schizophrenia in Japan in 2002. Nervenarzt 2011, 82(9):1160-1168.